Kontinuerlig behandling udover 5- 7 dage med stoffer, der har et CYP3A4/ 5- induktionspotentiale, bør derfor undgås.
Therefore, continuous administration beyond 5-7 days with agents that have CYP3A4/ 5 induction potential should be avoided.